Newsletter, M.D. – Your Guide to World Health

1. Death, Suffering, and now the Economy

Sierra Leone West Africa Ebola
In this pho­to tak­en on Tues­day, Aug 12, 2014, a health­care work­er, right, wears pro­tec­tive gear against the Ebo­la virus before he enters the Ebo­la iso­la­tion ward at Ken­e­ma Gov­ern­ment Hos­pi­tal in Free­town, Sier­ra Leone. (AP Photo/ Michael Duff)

WHO The peo­ple of the West African nations affect­ed by the Ebo­la epi­dem­ic, pre­dom­i­nant­ly Liberia, Sier­ra Leone and Guinea.

WHAT The eco­nom­ic ram­i­fi­ca­tions of the out­break, which has already result­ed in over 2,000 deaths. The New York Times report­ed Wednes­day that Liberi­a’s gross domes­tic prod­uct could drop by 12 per­cent as a result of the out­break, and that Sier­ra Leone’s GDP could fall by as much as 9 per­cent, accord­ing to a report from the World Bank Group. The prog­no­sis is trou­bling for oth­er rea­sons as well. If Ebo­la con­tin­ues to spread, oth­er neigh­bor­ing nations with larg­er economies will be at risk, as the virus is threat­en­ing to have a domi­no effect eco­nom­i­cal­ly across the continent.

The fear of con­ta­gion has helped fuel an eco­nom­ic cri­sis” – Dr. Jim Yong Kim, pres­i­dent of the World Bank Group.

WHEN Wednes­day, Sept. 17.

WHEREThe New York Times

WHY If it isn’t scaled back, the out­break – which is already a world­wide prob­lem – will start to affect the glob­al econ­o­my. The virus has­n’t spread to any nations out­side of Africa, but this sto­ry shows that the out­break is capa­ble of affect­ing oth­er coun­tries with­out infect­ing a sin­gle one of their citizens.

2. U.K. Leads the Way

WHO British vol­un­teer Ruth Atkins, the Uni­ver­si­ty of Oxford and U.K. drug giant GlaxoSmithKline.

WHAT An exper­i­men­tal Ebo­la vac­cine pro­duced by Glax­o­SmithK­line, which Hill became the first British vol­un­teer to be inject­ed with Wednes­day. Atkins said she felt fine one hour after receiv­ing the vac­ci­na­tion, which, if suc­cess­ful, will be fast tracked to be avail­able for aid work­ers in West Africa, accord­ing to The Guardian. The paper report­ed that 60 healthy peo­ple will be vac­ci­nat­ed to find out if there are any side effects. The Uni­ver­si­ty of Oxford, which is run­ning the tri­al, hopes to have the results before the end of this year.

Dr. Felicity Hartnell, who is a clinical research fellow at Oxford University, injects former nurse Ruth Atkins with an experimental vaccine against Ebola. (AP Photo/Steve Parsons)
Dr. Felic­i­ty Hart­nell, who is a clin­i­cal research fel­low at Oxford Uni­ver­si­ty, injects for­mer nurse Ruth Atkins with an exper­i­men­tal vac­cine against Ebo­la. (AP Photo/Steve Parsons)

These are ini­tial safe­ty tri­als of the vac­cine and it will be some time before we know whether the vac­cine could pro­tect peo­ple against Ebo­la. But we are opti­mistic that the can­di­date vac­cine may prove use­ful against the dis­ease in the future” – Pro­fes­sor Adri­an Hill, direc­tor of the Jen­ner Insti­tute at the Uni­ver­si­ty of Oxford.

WHEN Wednes­day, Sept. 17.

WHERE — The Guardian

WHY The sto­ry cov­ers the first major step being tak­en to intro­duce an effec­tive Ebo­la vac­cine into West Africa, where the dis­ease has been run­ning ram­pant. If the results of Oxford’s tri­al are pos­i­tive, then the world will be one step clos­er to con­tain­ing the outbreak.

3. Enterovirus D68 makes foray into N.J.

WHO The State of New Jersey

WHAT Enterovirus D68, the first case of which was con­firmed in New Jer­sey yes­ter­day by the Cen­ters for Dis­ease Con­trol and Pre­ven­tion. The child that was diag­nosed with the virus had been a patient at a Philadel­phia hos­pi­tal where oth­er chil­dren with D68 were being treated.

The New Jer­sey Depart­ment of Health is close­ly mon­i­tor­ing for increas­es in res­pi­ra­to­ry ill­ness in hos­pi­tals around the state” – Mary E. O’Dowd, New Jer­sey’s State Health Commissioner.

WHEN Wednes­day, Sept. 17.

WHERE — NJ.com

WHY While enterovirus­es are com­mon in the fall and win­ter, D68 has some par­ents wor­ried, large­ly due to its rar­i­ty and more-severe symp­toms, which have lead to hos­pi­tal­iza­tions. Basi­cal­ly, it’s some­thing you don’t want your kid to catch, so know­ing the states it has hit is important.

4. The Apple-a-Day Award

THE WINNER This week’s Apple-a-Day Award goes to Erin All­day of SFGate.com. All­day wrote a a pow­er­ful fea­ture on the Ebo­la out­break in West Africa and the toll it has tak­en on peo­ple like Dr. Dan Kel­ly, an infec­tious dis­ease spe­cial­ist at the Uni­ver­si­ty of Cal­i­for­nia-San Fran­cis­co. The sto­ry delves into the hope­less­ness that some in the med­ical field feel about the out­break, and the enor­mi­ty of the chal­lenge that lies before them in such an impov­er­ished region.

HONORABLE MENTIONS

5. From the Archives

YouTube film­mak­er Casey Nei­s­tat’s video on calo­rie labels for the New York Times’ Op-Doc series, from Feb. 2013.

Leave a Reply